FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

4089011000001100: Crinone 4% progesterone vaginal gel (Serono Laboratories (UK) Ltd) 6 unit dose (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
26971701000001112 Crinone 4% progesterone vaginal gel (Serono Laboratories (UK) Ltd) 6 unit dose (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
47199701000001117 Crinone 4% progesterone vaginal gel (Merck Serono Ltd) 6 unit dose en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Crinone 4% progesterone vaginal gel (Serono Laboratories (UK) Ltd) 6 unit dose Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Crinone 4% progesterone vaginal gel (Serono Laboratories (UK) Ltd) 6 unit dose Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Crinone 4% progesterone vaginal gel (Serono Laboratories (UK) Ltd) 6 unit dose Is a Progesterone 4% vaginal gel 2.6gram applicators 6 unit dose true Inferred relationship Existential restriction modifier
Crinone 4% progesterone vaginal gel (Serono Laboratories (UK) Ltd) 6 unit dose Is pack of Crinone 4% progesterone vaginal gel (Serono Laboratories (UK) Ltd) false Inferred relationship Existential restriction modifier
Crinone 4% progesterone vaginal gel (Serono Laboratories (UK) Ltd) 6 unit dose Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Crinone 4% progesterone vaginal gel (Serono Laboratories (UK) Ltd) 6 unit dose Has active ingredient Progesterone false Inferred relationship Existential restriction modifier
Crinone 4% progesterone vaginal gel (Serono Laboratories (UK) Ltd) 6 unit dose Has active ingredient Synthetic progestogen false Inferred relationship Existential restriction modifier
Crinone 4% progesterone vaginal gel (Serono Laboratories (UK) Ltd) 6 unit dose Has excipient Sorbic acid false Inferred relationship Existential restriction modifier
Crinone 4% progesterone vaginal gel (Serono Laboratories (UK) Ltd) 6 unit dose Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Crinone 4% progesterone vaginal gel (Serono Laboratories (UK) Ltd) 6 unit dose Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Crinone 4% progesterone vaginal gel (Serono Laboratories (UK) Ltd) 6 unit dose VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Crinone 4% progesterone vaginal gel (Serono Laboratories (UK) Ltd) 6 unit dose VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Crinone 4% progesterone vaginal gel (Serono Laboratories (UK) Ltd) 6 unit dose Has manufactured dose form Gel false Inferred relationship Existential restriction modifier
Crinone 4% progesterone vaginal gel (Serono Laboratories (UK) Ltd) 6 unit dose Has AMP Crinone 4% progesterone vaginal gel (Serono Laboratories (UK) Ltd) true Inferred relationship Existential restriction modifier
Crinone 4% progesterone vaginal gel (Serono Laboratories (UK) Ltd) 6 unit dose Has specific active ingredient Progesterone true Inferred relationship Existential restriction modifier
Crinone 4% progesterone vaginal gel (Serono Laboratories (UK) Ltd) 6 unit dose Has dispensed dose form Gel false Inferred relationship Existential restriction modifier
Crinone 4% progesterone vaginal gel (Serono Laboratories (UK) Ltd) 6 unit dose Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Crinone 4% progesterone vaginal gel (Serono Laboratories (UK) Ltd) 6 unit dose Has dispensed dose form Conventional release vaginal gel true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start